For ever odd wrote: » Looks like swing highs have formed across all major indexs on the daily charts. Unless there is a remarkable move (to the upside) in US markets this afternoon , I will be looking to short (fairly hard) indexs next week.
For ever odd wrote: » Short DAX @9565 tight stop 9585. Feeler trade, as I am a bit baffled as to what is going on today.
_Tombstone_ wrote: » A small bit??
For ever odd wrote: » API oil storage up to 7.1m, last week's storage -3.3m. 10m swing in a week, oil just cannot catch a break, if EIA report is high tomorrow.......
For ever odd wrote: » Kuroda is hinting at further rate cuts. Keep an eye on gold for clues, in particular 1232, a great level. Both should move in tandam, maybe hedge one off the other if in doubt. Yen 112.48 is my sticky point for the time being.
Auld Slapper wrote: » Hi all, I have been trying to find future prices of stocks but am having no luck. where should I go to find say the future price of Ryanair in 12 months? Many thanks
crooked_feet wrote: » bought freeport mc moran for $3.90 in january , sold yesterday @ $11.13 , think its due a pullback despite the bear rally in energy
RobertKK wrote: » Bought some Sarepta therapeutics (SRPT) during the week, when it was announced that the FDA will decide on their Duchenne Muscle Dystrophy drug next month. A genetic condition with currently no treatment. Bought in two tranches at $16.70 and $15.15. It then fell to a low of $14.26 on Wednesday before it was announced that insiders had bought $2.5 million worth of stock directly on the stock market, which was great news for shareholders. Currently at $18. It's 50 day movement average is in the $13s and the 200 day moving average is in the $27s. Planning on selling half before the decision and the rest for the risky outcome. The only thing going against it seems to be the small sample of clinical cases in the trial, but parents who have had the drugs used on their children are pleading for it to be approved. US Congress in the past couple of years had asked for the drug to be approved given there is currently no treatment and life expectancy at most is mid 20s. That is my biggest trade of the year so far. Expect it to get well into the 20s at least before the FDA decide if it goes way higher or way way lower. With the FDA, who knows.